HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Renal Dialysis (Hemodialysis)

Subscribe to New Research on Renal Dialysis

Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION.

Also Known As:

Hemodialysis; Dialysis, Renal; Dialyses, Extracorporeal; Dialyses, Renal; Extracorporeal Dialyses; Hemodialyses; Renal Dialyses; Dialysis, Extracorporeal; Extracorporeal Dialysis

Networked: 18530 relevant articles (764 outcomes, 1953 trials/studies) for this Therapy, Comments

Relationship Network

Therapy Context: Research Results

Therapeutics: 6379
- Renal Replacement Therapy: 1991
  - Renal Dialysis: 18530
- Sorption Detoxification: 25
  - Renal Dialysis: 18530

Experts

1.	Nishizawa, Yoshiki: 32 articles (03/2010 - 06/2002)
2.	Kalantar-Zadeh, Kamyar: 29 articles (07/2009 - 07/2003)
3.	Akiba, Takashi: 28 articles (01/2010 - 01/2002)
4.	Collins, Allan J: 27 articles (03/2010 - 03/2002)
5.	Ikizler, T Alp: 26 articles (11/2009 - 01/2002)
6.	Allon, Michael: 26 articles (11/2009 - 03/2002)
7.	Levin, Nathan W: 26 articles (04/2009 - 01/2002)
8.	Agarwal, Rajiv: 23 articles (02/2010 - 09/2002)
9.	Kimmel, Paul L: 23 articles (06/2009 - 06/2002)
10.	Ishimura, Eiji: 22 articles (03/2010 - 06/2002)

Related Diseases

1.	Chronic Kidney Failure (Chronic Renal Failure) 01/01/1996 - "Increasing use of medications designed specifically for intravenous administration during hemodialysis has dramatically improved the treatment of many comorbid conditions accompanying end-stage renal disease. " 06/01/1978 - "The records of 272 recipients of cadaver allografts and of 650 dialyzed patients (440 center dialysis and 210 home dialysis) were reviewed in an attempt to determine whether hemodialysis or transplantation is the best treatment for end-stage renal failure. " 01/01/2007 - "High Body Mass Index (BMI) has been associated with improved survival of End-Stage Renal Disease (ESRD) patients on chronic hemodialysis (HD); however, studies on the relationship of BMI with survival in Peritoneal Dialysis (PD) patients have yielded conflicting results. " 07/01/2006 - "Although hemodialysis (HD) has improved the life expectancy of patients with end-stage renal disease (ESRD), uremic patients continue to experience high morbidity and mortality. " 10/01/2001 - "After 2 years' follow-up, seven mothers achieved complete remission, three had died, three developed chronic renal failure (CRF), and two progressed to end stage renal failure (ESRF) requiring chronic hemodialysis. " Order ALL the reference details at left...
2.	Anemia 07/01/1983 - "Previous report on improvement in anemia most likely reflected the smaller loss of blood during CAPD compared with hemodialysis." 04/01/2007 - "CONCLUSION: This clinical study showed that Espogen has proven effective and safe for treatment of anemia in hemodialysis patients. " 02/01/1989 - "It is concluded that r-huEPO is very effective in treating the anemia of patients maintained on hemodialysis. " 05/01/1997 - "Our study suggests that improvement of anemia in patients on long-term hemodialysis by administration of EPO is associated with an improvement in hearing capacity in a significant number of patients. " 02/01/1993 - "Anemia contributes to significant debilitation in hemodialysis patients and, when reversed with epoetin therapy, results in significantly improved muscle function and endurance." Order ALL the reference details at left...
3.	Kidney Failure (Renal Failure) 06/01/1995 - "Seventeen (53%) patients attained a complete remission and 22 (69%) survived (five in advanced renal failure and long-term hemodialysis). " 06/01/2009 - "In renal failure animal models, acid-base parameters improved significantly after hemodialysis with ionized alkaline water compared with the conventional water treated with reverse osmosis (RO). " 08/01/1992 - "The accumulation of this E-21 IA in renal failure is evidence that the kidney has a major role in the clearance of this fragment, which is not accomplished by the membranes used in hemodialysis." 08/01/2009 - "Plasma exchanges were initially effective against the microangiopathic hemolytic activity and allowed a temporary improvement of renal function with termination of hemodialysis after 7 wk. Subsequently, plasma exchanges (three times per week) failed to prevent ongoing aHUS activity and progressive renal failure. " 04/01/2003 - "Depolymerized holothurian glycosaminoglycan (DHG), a novel alternative anticoagulant for hemodialysis, is safe and effective in a dog renal failure model." Order ALL the reference details at left...
4.	Secondary Hyperparathyroidism 07/01/2005 - "Here we present a hemodialysis patient with severe secondary hyperparathyroidism who was found to have abnormally higher plasma bio-intact-PTH concentrations than intact-PTH concentrations, and the abnormally high biointact-PTH/intact-PTH ratio improved after parathyroidectomy (PTx). " 06/01/1993 - "The patients in Group I responded well to hemodialysis and drug therapy, but those in Group II were likely to have secondary hyperparathyroidism. " 01/01/1984 - "The radiological and histological appearances of secondary hyperparathyroidism improved or seemed to worsen to a lesser degree in CAPD compared to hemodialysis patients." 11/01/2009 - "The aim of this study was to assess the role of color and spectral Doppler ultrasound (CDU) in the evaluation of enlarged parathyroid glands in hemodialysis patients with secondary hyperparathyroidism. " 05/01/2008 - "STUDY AIMS: To survey bone mineral disturbances in the hemodialysis (HD) population in Europe and current clinical practice in Europe for the prevention, diagnosis and treatment of secondary hyperparathyroidism (SHPT) in HD patients. " Order ALL the reference details at left...
5.	Infection 07/01/1987 - "Most catheter or shunt infections in hemodialysis patients require the removal of the access before the infection is eradicated. " 02/01/2005 - "Only in patients on hemodialysis or chronic ambulatory peritoneal dialysis (CAPD) was a significant reduction of the infection rate found. " 01/01/1992 - "The high rate of infection of hemodialysis patients with hepatitis C virus in our setting points to the need for improved control measures." 07/01/2007 - "CONCLUSION: Long-term central venous accesses using tunneled internal jugular catheters appeared to be safe and effective for both hemodialysis and long-term infusion therapies, with relatively higher infection rates in oncologic patients." 08/01/2008 - "With improved awareness within dialysis units of the potential for spread and the institution of preventative measures, the prevalence of HCV infection in the hemodialysis-dependent population has continued to decline since 1995. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Erythropoietin
2.	Iron
3.	Calcitriol (Calcijex)
4.	Calcium
5.	Creatinine
6.	Heparin (Liquaemin)
7.	hydroxide ion
8.	Carnitine (L-Carnitine)
9.	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
10.	Urea (Carbamide)

Related Therapies and Procedures

1.	Transplants (Transplant)
2.	Peritoneal Dialysis
3.	Continuous Ambulatory Peritoneal Dialysis (CAPD)
4.	Kidney Transplantation
5.	Hemoperfusion

blog comments powered by Disqus

TREATMENT OPTIONS
for Chronic Kidney Failure,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 862 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Evidence References
Sample PDF Report on Psoriasis >>

Price:

$8.50 USD & Delivery via PDF download
updates for 1 year

Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:

Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
Enable Experts: Quickly identify key researchers and their publications
Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
Research Network: Explore drug and disease relationships visually
Enable Mobile Interface: Access from your cellphone, iPhone or PDA

Price:

$45.00 USD access via web interface
1 year subscription

Request Bulk Institution License Details >>